Citric acid and potassium citrate combination

This classification denotes an alkalinizing agent combination drug. The first component of this drug is a carboxylic acid with the molecular formula C6H8O7.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2968PHW8QPm, and which is called citric acid. European Medicines Agency schedules citric acid monohydrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12482MIG. The term citrate is a U.S. FDA designation. SMILES: OC(CC(=O)O)(CC(=O)O)C(=O)O. The second component of this drug is an an electrolyte replacement agent with the molecular formula C6H5O7.3K.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EE90ONI6FF, chemically known as 1,2,3-propanetricarboxylic acid, 2-hydroxy-, tripotassium salt but generally known as potassium citrate, which bears US NIH Compound Identifier 13344. European Medicines Agency schedules Potassium citrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14973MIG. World Health Organization schedules potassium citrate in its Anatomical Therapeutic Chemical (ATC) Classification.